Shouyao Holdings(SH:688197) Xin Lang Cai Jing·2025-09-01 02:18Group 1 - The core viewpoint of the news is that Shouyao Holdings has seen a significant increase in its stock price, rising by 5.18% to reach 48.50 CNY per share, with a total market capitalization of 7.213 billion CNY [1] - Shouyao Holdings, established on April 19, 2016, and listed on March 23, 2022, specializes in the research and development of small molecule anti-tumor drugs, with 100% of its revenue coming from technology development and services [1] Group 2 - Among the top circulating shareholders of Shouyao Holdings, a fund under China Europe Fund, specifically the China Europe Medical Health Mixed A (003095), has entered the top ten shareholders, holding 1.1728 million shares, which accounts for 1.83% of the circulating shares [2] - The China Europe Medical Health Mixed A fund, established on September 29, 2016, has a current scale of 15.638 billion CNY and has achieved a year-to-date return of 28.82%, ranking 2520 out of 8254 in its category [2] Group 3 - The fund managers of China Europe Medical Health Mixed A are Ge Lan and Zhao Lei, with Ge Lan having a tenure of 10 years and 219 days, managing assets totaling 39.908 billion CNY, and achieving a best fund return of 125.88% during her tenure [3] - Zhao Lei has a tenure of 60 days, managing assets of 30.801 billion CNY, with a best fund return of 13.75% during his short tenure [3]